274 related articles for article (PubMed ID: 19702530)
1. Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.
Lin JH
Curr Drug Metab; 2009 Sep; 10(7):661-91. PubMed ID: 19702530
[TBL] [Abstract][Full Text] [Related]
2. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.
Tibbitts J; Canter D; Graff R; Smith A; Khawli LA
MAbs; 2016; 8(2):229-45. PubMed ID: 26636901
[TBL] [Abstract][Full Text] [Related]
3. Advances in PEGylation of important biotech molecules: delivery aspects.
Ryan SM; Mantovani G; Wang X; Haddleton DM; Brayden DJ
Expert Opin Drug Deliv; 2008 Apr; 5(4):371-83. PubMed ID: 18426380
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs.
Griffin BT; Guo J; Presas E; Donovan MD; Alonso MJ; O'Driscoll CM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):367-380. PubMed ID: 27320644
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides.
Datta-Mannan A
Drug Metab Dispos; 2019 Oct; 47(10):1100-1110. PubMed ID: 31043438
[TBL] [Abstract][Full Text] [Related]
6. Alternative delivery systems for peptides and proteins as drugs.
Eppstein DA; Longenecker JP
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):99-139. PubMed ID: 3052876
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic barriers to peptide and protein absorption.
Lee VH
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.
Kagan L
Drug Metab Dispos; 2014 Nov; 42(11):1890-905. PubMed ID: 25122564
[TBL] [Abstract][Full Text] [Related]
9. Orally active-targeted drug delivery systems for proteins and peptides.
Li X; Yu M; Fan W; Gan Y; Hovgaard L; Yang M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1435-47. PubMed ID: 24962803
[TBL] [Abstract][Full Text] [Related]
10. The role of pharmacokinetics in the development of biotechnologically derived agents.
Wills RJ; Ferraiolo BL
Clin Pharmacokinet; 1992 Dec; 23(6):406-14. PubMed ID: 1458760
[No Abstract] [Full Text] [Related]
11. Assessments of antibody biodistribution.
Glassman PM; Abuqayyas L; Balthasar JP
J Clin Pharmacol; 2015 Mar; 55 Suppl 3():S29-38. PubMed ID: 25707961
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and ADME characterizations of antibody-drug conjugates.
Lin K; Tibbitts J; Shen BQ
Methods Mol Biol; 2013; 1045():117-31. PubMed ID: 23913144
[TBL] [Abstract][Full Text] [Related]
13. Peptide and protein drug delivery to and into tumors: challenges and solutions.
Torchilin VP; Lukyanov AN
Drug Discov Today; 2003 Mar; 8(6):259-66. PubMed ID: 12623240
[TBL] [Abstract][Full Text] [Related]
14. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
Katsila T; Siskos AP; Tamvakopoulos C
Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.
Ferl GZ; Theil FP; Wong H
Biopharm Drug Dispos; 2016 Mar; 37(2):75-92. PubMed ID: 26461173
[TBL] [Abstract][Full Text] [Related]
16. Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of therapeutic biologics.
Xu X; Vugmeyster Y
AAPS J; 2012 Dec; 14(4):781-91. PubMed ID: 22864668
[TBL] [Abstract][Full Text] [Related]
17. Emerging strategies for the transdermal delivery of peptide and protein drugs.
Schuetz YB; Naik A; Guy RH; Kalia YN
Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
[TBL] [Abstract][Full Text] [Related]
18. Strategies for enhanced peptide and protein delivery.
McCrudden MT; Singh TR; Migalska K; Donnelly RF
Ther Deliv; 2013 May; 4(5):593-614. PubMed ID: 23647277
[TBL] [Abstract][Full Text] [Related]
19. Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development.
Wang J; Iyer S; Fielder PJ; Davis JD; Deng R
Biopharm Drug Dispos; 2016 Mar; 37(2):51-65. PubMed ID: 25869767
[TBL] [Abstract][Full Text] [Related]
20. [Absorption, distribution, metabolism, excretion and toxicity of biologics and its application in pharmacokinetic modeling].
Zhang CF; Xie HT; Pan GY
Yao Xue Xue Bao; 2016 Aug; 51(8):1202-8. PubMed ID: 29897713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
